Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Towards identifying new therapeutic targets in cancers attributable to HPV.

Trimble CL.

Gynecol Oncol. 2018 May;149(2):225-226. doi: 10.1016/j.ygyno.2018.03.061. No abstract available.

PMID:
29685611
2.

Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model.

Jin BY, Campbell TE, Draper LM, Stevanović S, Weissbrich B, Yu Z, Restifo NP, Rosenberg SA, Trimble CL, Hinrichs CS.

JCI Insight. 2018 Apr 19;3(8). pii: 99488. doi: 10.1172/jci.insight.99488. eCollection 2018 Apr 19.

3.

Correction: Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.

Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Trimble CL, Garland S, Tabrizi SN, Wentzensen N, Sitas F, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA.

PLoS Genet. 2018 Mar 1;14(3):e1007257. doi: 10.1371/journal.pgen.1007257. eCollection 2018 Mar.

4.

A primary role for human central memory cells in tissue immunosurveillance.

Gehad A, Teague JE, Matos TR, Huang V, Yang C, Watanabe R, O'Malley JT, Trimble CL, Kupper TS, Clark RA.

Blood Adv. 2018 Feb 13;2(3):292-298. doi: 10.1182/bloodadvances.2017011346.

5.

Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy.

Morrow MP, Kraynyak KA, Sylvester AJ, Dallas M, Knoblock D, Boyer JD, Yan J, Vang R, Khan AS, Humeau L, Sardesai NY, Kim JJ, Plotkin S, Weiner DB, Trimble CL, Bagarazzi ML.

Clin Cancer Res. 2018 Jan 15;24(2):276-294. doi: 10.1158/1078-0432.CCR-17-2335. Epub 2017 Oct 30.

6.

Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.

Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Trimble CL, Garland S, Tabrizi SN, Wentzensen N, Sitas F, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA.

PLoS Genet. 2017 Aug 14;13(8):e1006866. doi: 10.1371/journal.pgen.1006866. eCollection 2017 Aug. Erratum in: PLoS Genet. 2018 Mar 1;14 (3):e1007257.

7.

Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100.

Morrow MP, Kraynyak KA, Sylvester AJ, Shen X, Amante D, Sakata L, Parker L, Yan J, Boyer J, Roh C, Humeau L, Khan AS, Broderick K, Marcozzi-Pierce K, Giffear M, Lee J, Trimble CL, Kim JJ, Sardesai NY, Weiner DB, Bagarazzi ML.

Mol Ther Oncolytics. 2016 Nov 30;3:16025. doi: 10.1038/mto.2016.25. eCollection 2016.

8.

A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3).

Alvarez RD, Huh WK, Bae S, Lamb LS Jr, Conner MG, Boyer J, Wang C, Hung CF, Sauter E, Paradis M, Adams EA, Hester S, Jackson BE, Wu TC, Trimble CL.

Gynecol Oncol. 2016 Feb;140(2):245-52. doi: 10.1016/j.ygyno.2015.11.026. Epub 2015 Nov 23.

9.

Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital Tract.

Sun YY, Peng S, Han L, Qiu J, Song L, Tsai Y, Yang B, Roden RB, Trimble CL, Hung CF, Wu TC.

Clin Cancer Res. 2016 Feb 1;22(3):657-69. doi: 10.1158/1078-0432.CCR-15-0234. Epub 2015 Sep 29.

10.

Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial.

Trimble CL, Morrow MP, Kraynyak KA, Shen X, Dallas M, Yan J, Edwards L, Parker RL, Denny L, Giffear M, Brown AS, Marcozzi-Pierce K, Shah D, Slager AM, Sylvester AJ, Khan A, Broderick KE, Juba RJ, Herring TA, Boyer J, Lee J, Sardesai NY, Weiner DB, Bagarazzi ML.

Lancet. 2015 Nov 21;386(10008):2078-2088. doi: 10.1016/S0140-6736(15)00239-1. Epub 2015 Sep 17.

11.

Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies.

Wang JW, Jagu S, Wu WH, Viscidi RP, Macgregor-Das A, Fogel JM, Kwak K, Daayana S, Kitchener H, Stern PL, Gravitt PE, Trimble CL, Roden RB.

Clin Vaccine Immunol. 2015 Jul;22(7):806-16. doi: 10.1128/CVI.00799-14. Epub 2015 May 13.

12.

Immunoprevention of human papillomavirus-associated malignancies.

Wang JW, Hung CF, Huh WK, Trimble CL, Roden RB.

Cancer Prev Res (Phila). 2015 Feb;8(2):95-104. doi: 10.1158/1940-6207.CAPR-14-0311. Epub 2014 Dec 8. Review.

13.

HPV Infection-Associated Cancers: Next-Generation Technology for Diagnosis and Treatment.

Trimble CL.

Cancer Immunol Res. 2014 Oct;2(10):937-42. doi: 10.1158/2326-6066.CIR-14-0152. Review.

14.

Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγ.

Soong RS, Song L, Trieu J, Knoff J, He L, Tsai YC, Huh W, Chang YN, Cheng WF, Roden RB, Wu TC, Trimble CL, Hung CF.

Clin Cancer Res. 2014 Nov 1;20(21):5456-67. doi: 10.1158/1078-0432.CCR-14-0344. Epub 2014 Jun 3.

15.

Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions.

Maldonado L, Teague JE, Morrow MP, Jotova I, Wu TC, Wang C, Desmarais C, Boyer JD, Tycko B, Robins HS, Clark RA, Trimble CL.

Sci Transl Med. 2014 Jan 29;6(221):221ra13. doi: 10.1126/scitranslmed.3007323.

16.

Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173.

Coleman RL, Ali S, Levenback CF, Gold MA, Fowler JM, Judson PL, Bell MC, De Geest K, Spirtos NM, Potkul RK, Leitao MM Jr, Bakkum-Gamez JN, Rossi EC, Lentz SS, Burke JJ 2nd, Van Le L, Trimble CL.

Gynecol Oncol. 2013 Feb;128(2):155-9. doi: 10.1016/j.ygyno.2012.11.034. Epub 2012 Nov 29.

17.

Management of endometrial precancers.

Trimble CL, Method M, Leitao M, Lu K, Ioffe O, Hampton M, Higgins R, Zaino R, Mutter GL; Society of Gynecologic Oncology Clinical Practice Committee.

Obstet Gynecol. 2012 Nov;120(5):1160-75. doi: http://10.1097/AOG.0b013e31826bb121. Review.

18.

Vulvar intraepithelial neoplasia (VIN 2/3): comparing clinical outcomes and evaluating risk factors for recurrence.

Wallbillich JJ, Rhodes HE, Milbourne AM, Munsell MF, Frumovitz M, Brown J, Trimble CL, Schmeler KM.

Gynecol Oncol. 2012 Nov;127(2):312-5. doi: 10.1016/j.ygyno.2012.07.118. Epub 2012 Aug 4.

19.

Preventing human papillomavirus disease.

Trimble CL.

J Clin Oncol. 2012 Sep 1;30(25):3037-8. doi: 10.1200/JCO.2012.42.9787. Epub 2012 Jul 30. No abstract available.

PMID:
22851562
20.

Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study.

Levenback CF, Ali S, Coleman RL, Gold MA, Fowler JM, Judson PL, Bell MC, De Geest K, Spirtos NM, Potkul RK, Leitao MM Jr, Bakkum-Gamez JN, Rossi EC, Lentz SS, Burke JJ 2nd, Van Le L, Trimble CL.

J Clin Oncol. 2012 Nov 1;30(31):3786-91. doi: 10.1200/JCO.2011.41.2528. Epub 2012 Jul 2.

21.

Karyometry in atypical endometrial hyperplasia: a Gynecologic Oncology Group study.

Bartels PH, Garcia FA, Trimble CL, Kauderer J, Curtin J, Lim PC, Hess LM, Silverberg S, Zaino RJ, Yozwiak M, Bartels HG, Alberts DS.

Gynecol Oncol. 2012 Apr;125(1):129-35. doi: 10.1016/j.ygyno.2011.12.422. Epub 2011 Dec 9.

22.

New technologies for cervical cancer screening.

Brown AJ, Trimble CL.

Best Pract Res Clin Obstet Gynaecol. 2012 Apr;26(2):233-42. doi: 10.1016/j.bpobgyn.2011.11.001. Epub 2011 Nov 25. Review.

23.

Disparities in human papillomavirus vaccine completion among vaccine initiators.

Chou B, Krill LS, Horton BB, Barat CE, Trimble CL.

Obstet Gynecol. 2011 Jul;118(1):14-20. doi: 10.1097/AOG.0b013e318220ebf3.

24.

Impact of payer status on treatment of cervical cancer at a tertiary referral center.

Levinson KL, Bristow RE, Donohue PK, Kanarek NF, Trimble CL.

Gynecol Oncol. 2011 Aug;122(2):324-7. doi: 10.1016/j.ygyno.2011.04.038. Epub 2011 May 28.

25.

Cervical cancer screening.

Partridge EE, Abu-Rustum NR, Campos SM, Fahey PJ, Farmer M, Garcia RL, Giuliano A, Jones HW 3rd, Lele SM, Lieberman RW, Massad SL, Morgan MA, Reynolds RK, Rhodes HE, Singh DK, Smith-McCune K, Teng N, Trimble CL, Valea F, Wilczynski S; National Comprehensive Cancer Networks.

J Natl Compr Canc Netw. 2010 Dec;8(12):1358-86. No abstract available.

PMID:
21147902
26.

Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium.

Trimble CL, Clark RA, Thoburn C, Hanson NC, Tassello J, Frosina D, Kos F, Teague J, Jiang Y, Barat NC, Jungbluth AA.

J Immunol. 2010 Dec 1;185(11):7107-14. doi: 10.4049/jimmunol.1002756. Epub 2010 Oct 29.

27.

Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3.

Trimble CL, Peng S, Thoburn C, Kos F, Wu TC.

Cancer Immunol Immunother. 2010 May;59(5):799-803. doi: 10.1007/s00262-009-0806-4. Epub 2009 Dec 13.

28.

Tc17 CD8 T cells: functional plasticity and subset diversity.

Yen HR, Harris TJ, Wada S, Grosso JF, Getnet D, Goldberg MV, Liang KL, Bruno TC, Pyle KJ, Chan SL, Anders RA, Trimble CL, Adler AJ, Lin TY, Pardoll DM, Huang CT, Drake CG.

J Immunol. 2009 Dec 1;183(11):7161-8. doi: 10.4049/jimmunol.0900368. Epub 2009 Nov 16.

29.

Development of therapeutic HPV vaccines.

Trimble CL, Frazer IH.

Lancet Oncol. 2009 Oct;10(10):975-80. doi: 10.1016/S1470-2045(09)70227-X. Review.

30.

A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3.

Trimble CL, Peng S, Kos F, Gravitt P, Viscidi R, Sugar E, Pardoll D, Wu TC.

Clin Cancer Res. 2009 Jan 1;15(1):361-7. doi: 10.1158/1078-0432.CCR-08-1725.

31.

Human papillomavirus vaccination should be offered to young males: Counterpoint.

Trimble CL.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):809. doi: 10.1158/1055-9965.EPI-07-2930. No abstract available.

32.

Cervical cancer screening.

Partridge EE, Abu-Rustum N, Campos S, Fahey PJ, Greer BE, Lele SM, Lieberman RW, Lipscomb GH, Morgan M, Nava ME, Reynolds RK, Singh DK, Smith-McCune K, Teng N, Trimble CL, Valea F, Wilczynski S; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2008 Jan;6(1):58-82. No abstract available.

PMID:
18267060
33.

Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion.

Zhai Y, Kuick R, Nan B, Ota I, Weiss SJ, Trimble CL, Fearon ER, Cho KR.

Cancer Res. 2007 Nov 1;67(21):10163-72.

34.

A4. Preinvasive lesions of the cervix.

Ngan HYS, Trimble CL.

Int J Gynaecol Obstet. 2006 Nov;94 Suppl 1:S44-S49. doi: 10.1016/S0020-7292(07)60009-5.

PMID:
29644631
35.

The PapSpin: a reasonable alternative to other, more expensive liquid-based Papanicolaou tests.

Rosenthal DL, Geddes S, Trimble CL, Carson KA, Alli PM.

Cancer. 2006 Jun 25;108(3):137-43.

36.

Prospects for therapeutic HPV vaccines.

Trimble CL.

Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S249-50. No abstract available.

PMID:
16419216
37.

Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.

Zaino RJ, Kauderer J, Trimble CL, Silverberg SG, Curtin JP, Lim PC, Gallup DG.

Cancer. 2006 Feb 15;106(4):804-11.

38.

Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.

Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ 2nd, Alberts D, Curtin J.

Cancer. 2006 Feb 15;106(4):812-9.

39.

Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.

Trimble CL, Piantadosi S, Gravitt P, Ronnett B, Pizer E, Elko A, Wilgus B, Yutzy W, Daniel R, Shah K, Peng S, Hung C, Roden R, Wu TC, Pardoll D.

Clin Cancer Res. 2005 Jul 1;11(13):4717-23.

40.

Active and passive cigarette smoking and the risk of cervical neoplasia.

Trimble CL, Genkinger JM, Burke AE, Hoffman SC, Helzlsouer KJ, Diener-West M, Comstock GW, Alberg AJ.

Obstet Gynecol. 2005 Jan;105(1):174-81.

41.

Cervical cancer screening clinical practice guidelines in oncology.

Partridge EE, Abu-Rustum NR, Campos S, Edelson M, Fahey PJ, Fiorica J, Greer BE, Lieberman RW, Likes W, Molpus KL, Nava ME, Reynolds RK, Singh DK, Smith-McCune K, Soper J, Teng N, Trimble CL, Wilczynski S; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2004 Nov;2(6):570-87. No abstract available.

PMID:
19780301
42.

Effectiveness of screening for cervical cancer in an inpatient hospital setting.

Trimble CL, Richards LA, Wilgus-Wegweiser B, Plowden K, Rosenthal DL, Klassen A.

Obstet Gynecol. 2004 Feb;103(2):310-6.

43.

Ovarian tumors of low malignant potential.

Trimble CL, Trimble EL.

Oncology (Williston Park). 2003 Nov;17(11):1563-7; discussion 1567-70, 1575. Review.

44.

Long-term survival and patterns of care in women with ovarian tumors of low malignant potential.

Trimble CL, Kosary C, Trimble EL.

Gynecol Oncol. 2002 Jul;86(1):34-7.

PMID:
12079297
45.

Ovarian tumors of low malignant potential.

Trimble EL, Trimble CL.

Curr Treat Options Oncol. 2001 Apr;2(2):103-8. Review.

PMID:
12057128
46.

Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women.

Ahdieh L, Muñoz A, Vlahov D, Trimble CL, Timpson LA, Shah K.

Am J Epidemiol. 2000 Jun 15;151(12):1148-57.

PMID:
10905527
47.

Reproducibility of the histopathological classification of vulvar squamous carcinoma and intraepithelial neoplasia.

Trimble CL, Diener-West M, Wilkinson EJ, Zaino RJ, Kurman RJ, Shah KV.

J Low Genit Tract Dis. 1999 Apr;3(2):98-103.

PMID:
25950555
48.

Human papillomavirus-specific serologic response in vulvar neoplasia.

Sun Y, Hildesheim A, Brinton LA, Nasca PC, Trimble CL, Kurman RJ, Viscidi RP, Shah KV.

Gynecol Oncol. 1996 Nov;63(2):200-3.

PMID:
8910627
49.

Heterogeneous etiology of squamous carcinoma of the vulva.

Trimble CL, Hildesheim A, Brinton LA, Shah KV, Kurman RJ.

Obstet Gynecol. 1996 Jan;87(1):59-64.

PMID:
8532267
50.

Management of epithelial ovarian tumors of low malignant potential.

Trimble CL, Trimble EL.

Gynecol Oncol. 1994 Dec;55(3 Pt 2):S52-61. Review.

PMID:
7835812

Supplemental Content

Loading ...
Support Center